agilon health, inc. (NYSE:AGL - Get Free Report) Director Karen Mcloughlin bought 25,000 shares of the stock in a transaction on Friday, December 13th. The stock was purchased at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the acquisition, the director now directly owns 73,166 shares of the company's stock, valued at $160,965.20. The trade was a 51.90 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.
Shares of NYSE:AGL traded up $0.03 during mid-day trading on Friday, reaching $2.25. The stock had a trading volume of 3,068,318 shares, compared to its average volume of 4,856,405. The business's 50 day moving average price is $2.46 and its 200 day moving average price is $4.42. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $13.76. The company has a market cap of $927.05 million, a P/E ratio of -2.39 and a beta of 0.51.
agilon health (NYSE:AGL - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to analysts' expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the prior year, the company posted ($0.06) earnings per share. Research analysts expect that agilon health, inc. will post -0.52 EPS for the current fiscal year.
Several large investors have recently bought and sold shares of the stock. CWM LLC raised its holdings in agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company's stock worth $59,000 after purchasing an additional 7,288 shares during the period. Nisa Investment Advisors LLC purchased a new position in agilon health during the second quarter valued at $60,000. Neo Ivy Capital Management purchased a new stake in shares of agilon health during the second quarter worth about $1,006,000. Pallas Capital Advisors LLC acquired a new position in shares of agilon health during the 2nd quarter worth about $77,000. Finally, Bank of New York Mellon Corp boosted its holdings in agilon health by 18.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company's stock worth $7,252,000 after buying an additional 174,883 shares during the last quarter.
A number of research firms have weighed in on AGL. Evercore ISI decreased their price objective on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating for the company in a research report on Tuesday, October 8th. Bank of America cut shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price objective for the company. in a report on Wednesday, October 2nd. JMP Securities lowered agilon health from an "outperform" rating to a "market perform" rating in a research note on Monday, November 11th. TD Cowen dropped their target price on agilon health from $6.00 to $2.00 and set a "hold" rating on the stock in a report on Monday, November 11th. Finally, Sanford C. Bernstein initiated coverage on shares of agilon health in a research report on Wednesday. They set a "market perform" rating and a $2.50 target price on the stock. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, agilon health has a consensus rating of "Hold" and an average price target of $4.38.
View Our Latest Stock Analysis on AGL
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.